MedTrace Logo

Observational Study of Iron Overload in Stem Cell Transplantation

NCT00954720 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2013-02-28

No results posted yet for this study

Summary

Recent retrospective studies have suggested that iron overload is a clinically important problem in patients undergoing ablative stem cell transplantation. However, these studies relied on serum ferritin as a surrogate of iron overload, which limits the conclusions that can be drawn from such analyses. Therefore, the investigators are conducting a prospective study to more rigorously examine the prevalence, mechanisms, and consequences of iron overload in this patient population.

Conditions

Interventions

OTHER

No Intervention

There is no intervention on this trial

Sponsors & Collaborators

Principal Investigators

  • Philippe Armand, MD, PhD · Dana-Farber Cancer Institute

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2011-01-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00954720 on ClinicalTrials.gov